Therapeutic Solutions International
Manufacturing · Idaho, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
701 Wild Rose Ln, Elk City, Idaho, 83525...Phone Number
(760) 295-7208Revenue
<$5 MillionStock Symbol
TSOIIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Therapeutic Solutions International
Therapeutic Solutions International, Inc. focuses on immune modulation for the treatment of various specific diseases. The company develops a range of immune-modulatory agents to target cancers, enhance maternal and fetal health, and fight periodontal disease, as well as for daily health.Explore more
Therapeutic Solutions International Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Therapeutic Solutions International your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Therapeutic Solutions International, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Therapeutic Solutions International has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Therapeutic Solutions International has new funding data
Product Launch: Get notified when Therapeutic Solutions International launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Therapeutic Solutions International recently announced quarterly report
Check out if Therapeutic Solutions International is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Therapeutic Solutions International
Click to see if Therapeutic Solutions International had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined Therapeutic Solutions International as Masked Content
Find 3 more new buyers
Compare Similar Companies to Therapeutic Solutions International
Compare insights from companies similar to Therapeutic Solutions International, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Therapeutic Solutions International is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Therapeutic Solutions International is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Therapeutic Solutions International.
Therapeutic Solutions International financials insights
Gather financial insights about Therapeutic Solutions International, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2022
Share Placement
$10M
Therapeutic Solutions International Tech Stack
A closer look at the technologies used by Therapeutic Solutions International
See more technologies
Most Recent Scoops
Executive Move
Executive Moves, Board of Directors
Project
Research & Development, Intellectual Property, Legal Affairs
New Hire
Executive Move
Funding
Therapeutic Solutions International News & Media
Therapeutic Solutions International Receives Notice of Allowance for Landmark Patent Covering Cellular Therapy of Lung Diseases
ELK CITY, Idaho--(BUSINESS WIRE)--Therapeutic Solutions International, Inc. (TSOI) announced today receipt of a Notice of Allowance from the United States Patent and Trademark Office regarding its patent application entitled “Stimulation of Mesenchymal Stem Cell Therapeutics Activities by Regulatory T Cells.” The issued patent claims include: “A method of inhibiting lung inflammation comprising: a) identifying a subject suffering from lung inflammation; b) administering a population of T regulaImmunology Based Suicide Prevention Company Campbell Neurosciences ... - InvestorsObserver
Therapeutic Solutions International Pre-Spin-Off Company Plans to Enter Capital Markets Through Partial Distribution of its Shares to Shareholders of Parent Company Therapeutic Solutions International, Inc. (TSOI) Pre-Spin-Off Company Plans t...Immunology Based Suicide Prevention Company Campbell Neurosciences Announces Appointment of Public Company Veteran Raymond Oliver as Chairman of the Board
ELK CITY, Idaho--(BUSINESS WIRE)--Therapeutic Solutions International, Inc. (TSOI) Pre-Spin-Off Company Plans to Enter Capital Markets Through Partial Distribution of its Shares to Shareholders of Parent Company. Therapeutic Solutions International pre-spin-off company, Campbell Neurosciences, Inc., announced today appointment of seasoned public company veteran Mr. Raymond Oliver as Chairman of its Board of Directors. This move is part of a larger strategy the suicide prevention company is implTherapeutic Solutions International Granted Patent on Commercially Available QuadraMune® Nutraceutical for Increasing Natural Killer Cell Immunity in COVID-19 Patients
ELK CITY, Idaho--(BUSINESS WIRE)--Therapeutic Solutions International, Inc. (TSOI), a clinical-stage stem cell and immunotherapy company, announced today the granting of a patent covering the ability of QuadraMune® and similar compositions, to stimulate natural killer (NK) cell activity in patients with COVID-19. NK cells are the first line of defense against viruses and cancers1. The Company was previously awarded by the United States Patent and Trademark Office the following QuadraMune® relat
Read more news
Top Manufacturing Companies
See more top companies
Frequently Asked Questions Regarding Therapeutic Solutions International
Sign Up For FreeTo access detailed company insights
Therapeutic Solutions International, Inc. focuses on immune modulation for the treatment of various specific diseases. The company develops a range of immune-modulatory agents to target cancers, enhance maternal and fetal health, and fight periodontal disease, as well as for daily health.... Read More
